A, D., R, W., M, G., G, G., R, A., M, E., . . . GS, V. (2025). Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML. Blood, 146(10), 1239. https://doi.org/10.1182/blood.2024026113
Chicago Style (17th ed.) CitationA, Damaskou, et al. "Posttranscriptional Depletion of Ribosome Biogenesis Factors Engenders Therapeutic Vulnerabilities in NPM1-mutant AML." Blood 146, no. 10 (2025): 1239. https://doi.org/10.1182/blood.2024026113.
MLA (9th ed.) CitationA, Damaskou, et al. "Posttranscriptional Depletion of Ribosome Biogenesis Factors Engenders Therapeutic Vulnerabilities in NPM1-mutant AML." Blood, vol. 146, no. 10, 2025, p. 1239, https://doi.org/10.1182/blood.2024026113.
Warning: These citations may not always be 100% accurate.
